99% Savings - Buy Just @1 Rs X
Ropark 0.25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Parkinson's Disease, Restless Legs Syndrome. Ropark 0.25 Mg Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Ropark 0.25 Mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Ropark 0.25 Mg Tablet include Sleepiness, Weakness, Influenza like symptoms. Some other side effects of Ropark 0.25 Mg Tablet have been listed ahead. Such side effects of Ropark 0.25 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Ropark 0.25 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Ropark 0.25 Mg Tablet related warnings talks about Ropark 0.25 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Low Blood Pressure (Hypotension), Psychosis must refrain from the use of Ropark 0.25 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Ropark 0.25 Mg Tablet are listed in the contraindications section below.
Drug reaction of Ropark 0.25 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Ropark 0.25 Mg Tablet is considered not safe while driving, and is not addictive.
Ropark 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ropark 0.25 Mg Tablet safe for pregnant women?
Ropark may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Ropark again without your doctor's advice.
Is the use of Ropark 0.25 Mg Tablet safe during breastfeeding?
Ropark may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Ropark 0.25 Mg Tablet on the Kidneys?
Ropark may have mild side effects on the kidneys.
What is the effect of Ropark 0.25 Mg Tablet on the Liver?
Ropark is rarely harmful for the liver.
What is the effect of Ropark 0.25 Mg Tablet on the Heart?
Side effects of Ropark rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Ropark 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Ropark 0.25 Mg Tablet habit forming or addictive?
Ropark 0.25 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ropark 0.25 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Ropark 0.25 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Ropark 0.25 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Ropark 0.25 Mg Tablet
Taking Ropark 0.25 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ropark 0.25 Mg Tablet
Taking Ropark 0.25 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116